Abstract
<h3>In Reply.</h3> —Drs Wong and Lee present an interesting description of the situation of HIV infection among IDUs in Hong Kong. We were aware of the Hong Kong drug treatment program seroprevalence data, but not of their unpublished data from IDUs not in treatment. It would appear that Hong Kong meets our criteria for "stable low HIV prevalence" among IDUs.<sup>1</sup>We did consider pharmacy sales as "provision of sterile injection equipment" if pharmacists did not discriminate against IDUs and IDUs could carry injection equipment without fear of arrest or harassment by police. The data from Hong Kong thus seem fully parallel to the data from the five cities in our study. Given the effectiveness of methadone maintenance treatment in reducing heroin injection (and therefore HIV risk),<sup>2</sup>we would agree that the Hong Kong methadone treatment program probably was important in reducing HIV transmission there. We would also note
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
